Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Polyphor Ltd.

www.polyphor.com

Latest From Polyphor Ltd.

Road Ahead Unclear For Polyphor’s Intravenous Murepavadin

The Swiss firm is still examining options for the iv formulation of its novel antibiotic murepavadin even after it closed its two Phase III studies on safety concerns.

Clinical Trials Companies

QIDP Roundup: Familiar Names Dominate 2019 Designations

US FDA's Qualified Infectious Disease Product program is growing slowly, but still growing.

Review Pathway Infectious Diseases

Polyphor's Stock Slides As Murepavadin Trials Are Halted

The Switzerland-headquartered group has suffered a setback as a couple of Phase III trials of its lead antibiotic were stopped temporarily after an unexpectedly high number of patients reported kidney injury.

Infectious Diseases Clinical Trials

Finance Watch: 5AM, Longevity Close Funds, New Incubators Launch To Support Early-Stage Companies

News of 5AM's two latest venture funds follows the launch of Longevity Vision Fund as well as LA BioMed's and RUNLABS’ announcements that they will open new incubators in 2019. Also, Passage Bio launches with $115.5m, but the largest recent VC deal was HaiHe's $146.6m financing.

Financing StartUps and SMEs
See All

Company Information

  • Industry
  • Biotechnology
    • Drug Discovery Tools
  • Pharmaceuticals
  • Therapeutic Areas
  • Cancer
  • Immune Disorders
  • Infectious & Viral Diseases
  • Respiratory, Pulmonary
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • Switzerland
  • Parent & Subsidiaries
  • Polyphor Ltd.
  • Senior Management
  • Giacomo Di Nepi, CEO
    Kalina Scott, CFO
    Daniel Obrecht, PhD, CSO
    Helmut Kessmann, PhD, Head, Bus. Dev.
    Debra Barker, MD, CMO & Chief Dev. Officer
  • Contact Info
  • Polyphor Ltd.
    Phone: (41) 61 567 16 00
    Hegenheimermattweg 125
    Allschwil, CH-4123
    Switzerland
Advertisement
Advertisement
UsernamePublicRestriction

Register